FIMG
REGN icon

Financial & Investment Management Group’s Regeneron Pharmaceuticals REGN Stock Holding History

Financial & Investment Management Group’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		$3.52M Sell
9,427
-1,109
-11% -$406K 1.28% 26
2018
Q3 		$4.26M Sell
10,536
-314
-3% -$120K 1.4% 27
2018
Q2 		$3.74M Buy
10,850
+7,364
+211% +$2.3M 1.18% 34
2018
Q1 		$1.2M Buy
+3,486
New +$1.21M 0.39% 56

Other funds holding REGN

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Financial & Investment Management Group's REGN Position: Q4 2018 in Review

Financial & Investment Management Group reduced its Regeneron Pharmaceuticals (REGN) stake by 11% in Q4 2018, selling an estimated $406K and leaving 9,427 shares worth $3.52M. The position accounts for 1.28% of the portfolio, ranked #26.

Financial & Investment Management Group first reported a position in REGN in Q1 2018 and has held it in 4 quarters since. The position peaked at $4.26M in Q3 2018. 670 funds tracked by Wall St. Rank hold REGN as of Q4 2018.

  • Financial & Investment Management Group held 9,427 shares of Regeneron Pharmaceuticals worth $3.52M as of Q4 2018.
  • Financial & Investment Management Group sold 1,109 Regeneron Pharmaceuticals shares in Q4 2018, an estimated $406K.
  • Regeneron Pharmaceuticals made up 1.28% of Financial & Investment Management Group's portfolio in Q4 2018, its #26 holding.
  • Financial & Investment Management Group first reported a position in Regeneron Pharmaceuticals in Q1 2018 and has held it in 4 quarters since.
  • Financial & Investment Management Group's Regeneron Pharmaceuticals position peaked at $4.26M in Q3 2018.
  • 670 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q4 2018.

Based on Financial & Investment Management Group's 13F filing for Q4 2018, filed 30 Jan 2019.